Comparative pharmacokinetics of cefquinome following intravenous and intramuscular administration in goats

被引:33
作者
Dumka, Vinod Kumar [1 ]
Dinakaran, V. [1 ]
Ranjan, Bibhuti [1 ]
Rampal, Satyavan [1 ]
机构
[1] Guru Angad Dev Vet & Anim Sci Univ, Dept Vet Pharmacol & Toxicol, Ludhiana 141004, Punjab, India
关键词
Pharmacokinetics; Cefquinome; Goats; Bioavailability; BROAD-SPECTRUM CEPHALOSPORIN; ESCHERICHIA-COLI; DOSAGE REGIMENS; PHARMACODYNAMICS; BIOAVAILABILITY; INTEGRATION; INFECTIONS; BACTERIA; ANIMALS; INVITRO;
D O I
10.1016/j.smallrumres.2013.02.010
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
The comparative pharmacokinetic profile of cequinome following single intravenous (IV) and intramuscular (IM) administration of 2 mg/kg bodyweight was investigated in goats to determine the potential dosage regimen against susceptible microorganisms. Plasma concentrations of cefquinome were determined by high performance liquid chromatography. Plasma cefquinome disposition followed two-compartmental and mono-compartmental open models after IV and IM injection, respectively. Following IV injection, the major pharmacokinetic parameters (mean +/- SEM) were t(1/2 alpha) 1.17 +/- 0.22 h, t(1/2 beta) 5.76 +/- 0.19 h, V-d(area) 0.51 +/- 0.05 L/kg, AUC 33.83 +/- 2.53 mu g/mL, Cl-B 0.06 +/- 0.004 L/h/kg and MRT 6.09 +/- 0.11 h. After IM administration, the principal pharmacokinetic parameters (mean +/- SEM) were, C-max 4.84 +/- 0.23 mu g/mL, T-max 1.5 h, t(1/2k alpha) 0.64 +/- 0.23 h, t(1/2 beta) 5.86 +/- 0.29 h, AUC 19.82 +/- 2.07 mu gh/mL and MRT 8.08 +/- 10.50 h. The bioavailability after IM injection was 57.39 +/- 3.40%. A dosage regimen of 2 mg/kg body weight at 24 h interval following IV or IM injection would maintain the plasma levels required to be effective against the bacterial pathogens with MIC values <= 0.39 mu g/mL. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 29 条
[1]   Evaluation of ceftiofur and cefquinome for phenotypic detection of methicillin resistance in Staphylococcus aureus using disk diffusion testing and MIC-determinations [J].
Aarestrup, Frank M. ;
Skov, Robert L. .
VETERINARY MICROBIOLOGY, 2010, 140 (1-2) :176-179
[2]  
Al-Taher AY, 2010, J ANIM VET ADV, V9, P848, DOI 10.3923/javaa.2010.848.852
[3]  
Allan M. J., 2003, Journal of Veterinary Pharmacology and Therapeutics, V26, P104
[4]  
Batzias GC, 2009, J VET PHARMACOL THER, V32, P68
[5]   Residue analysis of 15 penicillins and cephalosporins in bovine muscle, kidney and milk by liquid chromatography-tandem mass spectrometry [J].
Becker, M ;
Zittlau, E ;
Petz, M .
ANALYTICA CHIMICA ACTA, 2004, 520 (1-2) :19-32
[6]  
Bryskier A., 1997, CLIN MICROBIOL INFEC, V3, P1, DOI DOI 10.1111/j.1469-0691.1997.tb00642.x
[7]   INVITRO ACTIVITY OF CEFQUINOME, A NEW CEPHALOSPORIN, COMPARED WITH OTHER CEPHALOSPORIN ANTIBIOTICS [J].
CHIN, NX ;
GU, JW ;
FANG, W ;
NEU, HC .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1992, 15 (04) :331-337
[8]   INTERRELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS IN DETERMINING DOSAGE REGIMENS FOR BROAD-SPECTRUM CEPHALOSPORINS [J].
CRAIG, WA .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 22 (1-2) :89-96
[9]  
CVMP, 1999, EMEAMRL54599 CVMP EU
[10]  
CVMP, 2003, EMEAMRL88303 CVMP EU